NERV Logo

Minerva Neurosciences, Inc. (NERV) 

NASDAQ
Market Cap
$22.03M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
669 of 809
Rank in Industry
365 of 445

Largest Insider Buys in Sector

NERV Stock Price History Chart

NERV Stock Performance

About Minerva Neurosciences, Inc.

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Insider Activity of Minerva Neurosciences, Inc.

Over the last 12 months, insiders at Minerva Neurosciences, Inc. have bought $0 and sold $0 worth of Minerva Neurosciences, Inc. stock.

On average, over the past 5 years, insiders at Minerva Neurosciences, Inc. have bought $20,020 and sold $131,347 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 7,000 shares for transaction amount of $20,790 was made by VAN HEEK G JAN (director) on 2020‑09‑10.

List of Insider Buy and Sell Transactions, Minerva Neurosciences, Inc.

2023-05-02SaleLuthringer RemyCEO
3,641
0.0559%
$3.76$13,690+44.22%
2023-05-01SaleLuthringer RemyCEO
23,753
0.4554%
$3.85$91,449+76.06%
2023-05-01SaleRace GeoffPresident
22,082
0.4234%
$3.85$85,016+76.06%
2023-05-01SaleAhlholm Frederick WSVP, CFO and Secretary
3,580
0.0799%
$4.48$16,038+76.06%
2021-12-01SaleKupfer Daviddirector
55,635
0.1267%
$0.88$48,959-24.75%
2020-12-16SaleRace GeoffEVP, CFO & CBO
6,190
0.0149%
$2.64$16,342-10.31%
2020-12-16SaleLuthringer RemyCEO
1,300
0.0031%
$2.64$3,432-10.31%
2020-12-16SaleReilly Joseph H.SVP & Chief Operating Officer
3,228
0.0078%
$2.64$8,522-10.31%
2020-12-16SaleAhlholm Frederick WSVP, Chief Accounting Officer
1,845
0.0044%
$2.64$4,871-10.31%
2020-09-10PurchaseVAN HEEK G JANdirector
7,000
0.0171%
$2.97$20,790-0.86%
2020-05-26SaleAhlholm Frederick WSVP, Chief Accounting Officer
8,339
0.0216%
$15.00$125,085-78.03%
2019-12-17SaleRace GeoffEVP, CFO & CBO
5,826
0.0152%
$7.10$41,365-46.98%
2019-12-17SaleLuthringer RemyCEO
2,412
0.0063%
$7.10$17,125-46.98%
2019-12-17SaleReilly Joseph H.SVP & Chief Operating Officer
2,724
0.0071%
$7.10$19,340-46.98%
2019-12-17SaleAhlholm Frederick WSVP, Chief Accounting Officer
1,557
0.0041%
$7.10$11,055-46.98%
2019-12-12SaleRussell Richard E.President
3,113
0.0078%
$7.42$23,098-50.13%
2019-06-27PurchaseDOYLE WILLIAM Fdirector
3,500
0.009%
$5.50$19,250+23.53%
2019-06-26PurchaseKupfer Daviddirector
10,000
0.0264%
$5.55$55,500+25.05%
2019-06-26PurchaseVAN HEEK G JANdirector
10,000
0.0255%
$5.37$53,700+25.05%
2019-06-26PurchaseHASLER HANS PETERdirector
10,000
0.0266%
$5.60$56,000+25.05%

Insider Historical Profitability

<0.0001%
Ollier Michele
4488272
64.1786%
$3.1521<0.0001%
De Rubertis Francesco
4488272
64.1786%
$3.1521<0.0001%
Index Venture Associates III Ltd10 percent owner
3899189
55.7552%
$3.15218<0.0001%
JOHNSON & JOHNSON10 percent owner
3892256
55.6561%
$3.1520<0.0001%
Pellegrini Lorenzo
3883212
55.5267%
$3.1510<0.0001%
Care Capital III LLC10 percent owner
1662592
23.7737%
$3.1517<0.0001%
Kupfer Daviddirector
163553
2.3387%
$3.1541+32.29%
Luthringer RemyCEO
68994
0.9866%
$3.1508
Race GeoffPresident
51324
0.7339%
$3.1517<0.0001%
Beer Marc Ddirector
50000
0.715%
$3.1520<0.0001%
Vivaldi Coelho RogerioPresident and CEO
41667
0.5958%
$3.1510<0.0001%
Russell Richard E.President
33770
0.4829%
$3.1502
Reilly Joseph H.SVP & Chief Operating Officer
31747
0.454%
$3.1517<0.0001%
DOYLE WILLIAM Fdirector
26111
0.3734%
$3.15110<0.0001%
VAN HEEK G JANdirector
20333
0.2907%
$3.1530<0.0001%
Ahlholm Frederick WSVP, CFO and Secretary
17518
0.2505%
$3.1518<0.0001%
HASLER HANS PETERdirector
10000
0.143%
$3.1510
HILLEMAN JERYL Ldirector
1000
0.0143%
$3.1510
Levine Mark S.SVP,General Counsel & Sec.
0
0%
$3.1502

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Federated Hermes$3.49M19.321.35M0%+$00.01
The Vanguard Group$650,315.003.6252,060+22.86%+$121,017.52<0.0001
Renaissance Technologies$459,000.002.54177,765+65.83%+$182,203.11<0.01
Ubs Oconnor Llc$257,082.001.4399,644+54.14%+$90,300.170.02
BlackRock$187,486.001.0472,6690%+$0<0.0001
Geode Capital Management$135,723.000.7552,592+0.96%+$1,290.34<0.0001
Northern Trust$59,563.000.3323,086-7.6%-$4,902.09<0.0001
Acadian Asset Management$44,000.000.2517,4230%+$0<0.0001
Susquehanna International Group$43,037.000.2416,681New+$43,037.00<0.0001
State Street$42,619.000.2416,5190%+$0<0.0001
Morgan Stanley$27,728.000.1510,747+70.97%+$11,509.69<0.0001
Tower Research Capital$10,586.000.064,103+201.69%+$7,077.11<0.0001
Wells Fargo$7,691.000.042,981+50.56%+$2,582.59<0.0001
Russell Investments Group Ltd$3,031.000.021,1750%+$0<0.0001
Royal Bank of Canada$1,000.000.01549+11.13%+$100.18<0.0001
TFC Financial$480.00<0.011860%+$0<0.0001
Bank of America$322.00<0.01125-2.34%-$7.73<0.0001
Sandy Spring Bank$258.00<0.01100New+$258.00<0.0001
Northwestern Mutual Wealth Management Co$258.00<0.011000%+$0<0.0001
UBS$26.00<0.0110-84.61%-$143.00<0.0001